Literature DB >> 18134

Partial purification and properties of frog liver tyrosine aminotransferase.

J J Ohisalo, S M Andersson, J P Pispa.   

Abstract

Hepatic tyrosine aminotransferase of the frog Rana temporaria was partially purified by (NH4)2SO4 fractionation and successive chromatography on DEAE-cellulose DE-52, Ultrogel AcA-34, DEAE-cellulose DE-52 again and, finally, hydroxyapatite. During the last step, the enzyme activity separated into two fractions; traces of a third fraction were also found. The major form was purified 6000-fold to a specific activity of 200 units/mg of protein; it was about 50% pure by electrophoretic criteria. It had mol.wt. about 85 000 as determined by gel filtration on a Sephadex G-100 column. It was not activated by added pyridoxal 5'-phosphate. The enzyme was, however, inactivated by the pyridoxal phosphate reactants canaline and amino-oxyacetate. The enzyme was specific for 2-oxoglutarate as the amino group acceptor. Homogentisate inhibited the enzyme and adrenaline was an activator; both effects were seen at low concentrations of the effectors. The relationship between initial rate and tyrosine or 2-oxoglutarate concentration was abnormal and complex. Form-2 enzyme had similar or identical molecular weight, cofactor requirements, oxo acid specificity and kinetics.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 18134      PMCID: PMC1164719          DOI: 10.1042/bj1630411

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  21 in total

1.  The isolation of albumin from blood serum or plasma by means of organic solvents.

Authors:  S E MICHAEL
Journal:  Biochem J       Date:  1962-01       Impact factor: 3.857

2.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

3.  Tyrosine transaminase: inactivation by tyrosine metabolic end products.

Authors:  M Civen; C Wilson; C B Brown
Journal:  Biochim Biophys Acta       Date:  1970-04-22

4.  Inhibition of tyrosine transaminase activity by norepinephrine.

Authors:  I B Black; J Axelrod
Journal:  J Biol Chem       Date:  1969-11-25       Impact factor: 5.157

5.  Purification and properties of rat liver tyrosine aminotransferase.

Authors:  F A Valeriote; F Auricchio; G M Tomkins; D Riley
Journal:  J Biol Chem       Date:  1969-07-10       Impact factor: 5.157

6.  Initiation by glucagon of the premature development of tyrosine aminotransferase, serine dehydratase, and glucose-6-phosphatase in fetal rat liver.

Authors:  O Greengard; H K Dewey
Journal:  J Biol Chem       Date:  1967-06-25       Impact factor: 5.157

7.  Regulation of tyrosine-alpha-ketoglutarate transaminase in rat liver. VII. Hormonal effects of synthesis in the isolated, perfused liver.

Authors:  C B Hager; F T Kenney
Journal:  J Biol Chem       Date:  1968-06-25       Impact factor: 5.157

8.  The enzymic synthesis of cysteine from inorganic sulphide and L-serine by rat liver preparations.

Authors:  J A Huovinen
Journal:  Ann Med Exp Biol Fenn       Date:  1968

9.  Negative cooperativity in regulatory enzymes.

Authors:  A Levitzki; D E Koshland
Journal:  Proc Natl Acad Sci U S A       Date:  1969-04       Impact factor: 11.205

10.  Tyrosine-alpha-ketoglutarate transaminase: induction by epinephrine and adenosine-3',5'-cyclic phosphate.

Authors:  W D Wicks
Journal:  Science       Date:  1968-05-31       Impact factor: 47.728

View more
  2 in total

1.  Testing and characterizing enzymes and membrane-bound carrier proteins acting on amphipathic ligands in the presence of bilayer membrane material and soluble binding protein. Application to the uptake of oleate into isolated cells.

Authors:  K P Heirwegh; J A Meuwissen
Journal:  Biochem J       Date:  1992-06-01       Impact factor: 3.857

Review 2.  Cystathionine-β-Synthase: Molecular Regulation and Pharmacological Inhibition.

Authors:  Karim Zuhra; Fiona Augsburger; Tomas Majtan; Csaba Szabo
Journal:  Biomolecules       Date:  2020-04-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.